You are here

Molecular Imaging

Molecular Imaging

2017 Impact Factor: 1.414
2017 Ranking: 96/128 in Radiology, Nuclear Medicine & Medical Imaging | 64/79 in Biochemical Research Methods
Source: Journal Citation Reports®, 2018 release, a Clarivate Analytics product; Indexed in PubMed: MEDLINE; Indexed in PubMed Central

Editor-in-Chief
Henry VanBrocklin, PhD University of California, San Francisco, USA


eISSN: 15360121 | ISSN: 15360121 | Current volume: 16 | Current issue: 1 Frequency: Not Yet Specified

Journal Highlights

  • Impact Factor: 1.414
  • Indexed In: Clarivate Analytics: Science Citation Index Expanded (SCIE), PubMed Central (PMC), PubMed: MEDLINE
  • Launched in: 2002
  • Publication is subject to payment of an article processing charge (APC)
  • Submit here


Molecular Imaging (MIX) is a peer-reviewed open access journal which focuses on the breadth of molecular imaging research from basic science to preclinical studies to human applications. Please see the Aims and Scope tab for further information.

This journal is published in Association with Society of Nuclear Medicine and Molecular Imaging.

This journal is a member of the Committee on Publication Ethics (COPE).


Submission Information

Submit your manuscript today at https://mc.manuscriptcentral.com/mix.

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.


Open access article processing charge (APC) information

Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license.

The APC for this journal is currently 1200 USD.

As of 1 January 2019 the APC will increase to 2000 USD.

As the APC is based on the date of original peer review submission, all articles submitted before 1 January 2019 will remain eligible for the lower APC regardless of the article's date of acceptance.

The article processing charge (APC) is payable only if your article is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.

Society for Nuclear Medicine and Molecular Imaging (SNMMI) members are eligible for a 50% discount off the prevailing APC.


Contact

Please direct any queries to erin.obrien@sagepub.com.

 

Molecular Imaging (MIX) is a peer-reviewed journal highlighting the breadth of molecular imaging research from basic science to preclinical studies to human applications. MIX covers all imaging modalities including:

  • Nuclear
  • Optical
  • Magnetic Resonance
  • Ultrasound
  • Photoacoustic
  • CT
  • Magnetic Particle Imaging

Additionally, MIX covers:

  • Development, application and validation of molecular imaging contrast agents
  • Probes for cellular and molecular targets (proteins, receptors, enzymes, genes and gene products that are present as a result of normal function or disease)
  • In vitro and in vivo assay methodology
  • Quantitative imaging and kinetic modeling
  • Animal model systems supporting targeted imaging approaches
  • Development, testing and validation of imaging devices

Molecular Imaging has been continuously published since 2002. The journal encourages the submission of unsolicited Reviews and papers reporting null or negative results in addition to Research Articles, Brief Reports and Meeting Reports.

This journal will be of particular interest to:

  • Molecular Imaging Scientists and Physicians
  • Basic and Translational Cancer Researchers
  • Medical Physicists
  • Radiopharmaceutical and Medicinal Chemists
  • Cell and Molecular, Chemical, and Systems Biologists
  • Pharmacologists

Submit your paper at https://mc.manuscriptcentral.com/mix.

Click here to read the full author guidelines.

Editor-in-Chief
Henry VanBrocklin, PhD University of California, San Francisco, USA
Managing Editor
Elaine Ellerton, PhD SAGE Publishing, Thousand Oaks, CA USA
Associate Editors
Walter J. Akers, PhD St. Jude Children's Research Hospital, Memphis, TN, USA
Ali Azhdarinia, PhD University of Texas Health Science Center, Houston, TX, USA
Kayvan Keshari, PhD Memorial Sloan Kettering Cancer Center, New York, NY, USA
Eva Sevick, PhD University of Texas Health Science Center, Houston, TX, USA
Neil Vasdev, PhD Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Editorial Board
Carolyn J. Anderson, PhD University of Pittsburgh, Pittsburgh, PA, USA
Zaver Bhujwalla, PhD Johns Hopkins University, Baltimore, MD, USA
Alexei Bogdanov, PhD University of Massachusetts, Worcester, MA, USA
Jeff Bulte, PhD Johns Hopkins University, Baltimore, MD, USA
Simon Cherry, PhD University of California, Davis, Davis, CA, USA
Christopher Contag, PhD Michigan State University, East Lansing, MI, USA
Charles Cunningham, PhD Sunnybrook Health Sciences Centre, University of Toronto, Canada
Sanjiv Gambhir, MD, PhD Stanford University, Stanford, CA, USA
Robert J. Gillies, PhD University of Arizona, Tucson, AZ, USA
Jan Grimm, MD, PhD Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Richard Hargreaves, PhD Celgene Corp., Summit, NJ, USA
Jason Holland, PhD University of Zurich, Zurich, Switzerland
Andreas Jacobs, MD, PhD Westfälische Wilhelms-Universität Münster, Germany
Kim Kelly, PhD University of Virginia, Charlottesville, VA, USA
Steven Liang, PhD Harvard Medical School, Boston, MA, USA
Umar Mahmood, PhD, MD Massachusetts General Hospital, Boston, MA, USA
Todd E. Peterson, PhD Vanderbilt University Medical Center, Nashville, TN, USA
Sally Schwartz, RPh, MS Washington University in St. Louis, St. Louis, MO, USA
Ming-Rong Zhang, PhD National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan
  • Adis International
  • ArticleFirst
  • Clarivate Analytics: Science Citation Index Expanded (SCIE)
  • EBSCOhost
  • OCLC: Electronic Collections Online
  • ProQuest
  • PubMed Central (PMC)
  • PubMed: MEDLINE
  • This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing,
    and Publication of Scholarly Work in Medical Journals formulated by the International Committee of
    Medical Journal Editors (ICMJE).

    Please read the guidelines below then visit the journal’s submission site https://mc.manuscriptcentral.com/mix to upload your manuscript. Please note that manuscripts not
    conforming to these guidelines may be returned.

    Only manuscripts of sufficient quality that meet the aims and scope of Molecular Imaging will be
    reviewed.

    As part of the submission process you will be required to warrant that you are submitting your original
    work, that you have the rights in the work, that you are submitting the work for first publication in the
    Journal and that it is not being considered for publication elsewhere and has not already been published
    elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of
    any copyright works not owned by you.

    Please Read the Manuscript Submission Guidelines below before submitting your manuscript here:
    SUBMIT MANUSCRIPT

     

    1. Open Access
    2. Article processing charge (APC)
    3. What do we publish?
      3.1 Aims & scope
      3.2 Article types
      3.3 Writing your paper
      3.3.1 Making your article discoverable 
    4. Editorial policies
      4.1 Peer Review Policy
      4.2 Authorship
      4.3 Acknowledgements
      4.3.1 Writing assistance
      4.4 Funding
      4.5 Declaration of conflicting interests
      4.6 Research ethics and patient consent
      4.7 Clinical Trials
      4.8 Reporting guidelines
      4.9 Data
    5. Publishing policies
      5.1 Publication ethics
      5.2 Contributor's publishing agreement
    6. Preparing your manuscript
      6.1 Word processing formats
      6.2 Artwork, figures and other graphics
      6.3 Supplementary material
      6.4 Reference style
      6.5 English language editing services
    7. Submitting your manuscript
      7.1 How to submit your manuscript
      7.2 Title, keywords and abstracts
      7.3 Information required for completing your submission
      7.4 ORCID
      7.5 Permissions
    8. On acceptance and publication
      8.1 SAGE Production
      8.2 Continuous publication
      8.3 Promoting your article
    9. Further information

    1. Open Access

    Molecular Imaging is an open access, peer-reviewed journal. Each article accepted by peer review is
    made freely available online immediately upon publication, is published under a Creative Commons
    license and will be hosted online in perpetuity. Publication costs of the journal are covered by the
    collection of article processing charges which are paid by the funder, institution or author of each
    manuscript upon acceptance. There is no charge for submitting a paper to the journal.

    For general information on open access at SAGE please visit the Open Access page or view our Open
    Access FAQs
    .

    Back to top

    2. Article processing charge (APC)

    If, after peer review, your manuscript is accepted for publication, a one-time article processing charge
    (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely
    available online in perpetuity under a Creative Commons licence.

    The APC for this journal is currently $1,200 USD.

    As of 1 January 2019 the APC will increase to $2,000 USD. 

    As the APC is based on the date of original peer review submission, all articles submitted before 1 January 2019 will remain eligible for the lower APC regardless of the article's date of acceptance.

    The article processing charge (APC) is payable only if your article is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.

    SNMMI (Society for Nuclear Medicine and Molecular Imaging) members receive a 50% discount on the
    APC.

    Back to top

    3. What do we publish?

    3.1 Aims & scope

    Before submitting your manuscript to Molecular Imaging, please ensure you have read the Aims
    & Scope.

    3.2 Article types

    Molecular Imaging publishes Research Articles, Brief Reports, Reviews and Meeting Reports.

    Research Reports are full length original articles.

    Brief Reports are short, timely articles which may provide preliminary accounts of work of
    special interest or complete accounts of work of limited scope. While there are no specific
    length limitations for Brief Reports, authors are encouraged to keep them concise.

    Authors wishing to contribute a Review should contact the Editor. Reviews should focus on a
    recent development or issue in a single area, rather than attempt to exhaustively cover an entire
    topic.

    Meeting Reports should offer a synthesis of information presented at a scientific meeting that
    would be of interest to the general readership.

    3.3 Writing your paper

    The SAGE Author Gateway has some general advice and on how to get published, plus links to
    further resources.

    3.3.1 Making your article discoverable 

    When writing up your paper, think about how you can make it discoverable. The title,
    keywords and abstract are key to ensuring readers find your article through search
    engines such as Google. For information and guidance on how best to title your article,
    write your abstract and select your keywords, have a look at this page on the Gateway:
    How to Help Readers Find Your Article Online

    Back to top

    4. Editorial policies

    4.1 Peer review policy

    Following a preliminary triage to eliminate submissions unsuitable for Molecular Imaging all
    papers are sent out for review. The covering letter is important. To help the Editor in his
    preliminary evaluation, please indicate why you think the paper suitable for publication. If your
    paper should be considered for fast-track publication, please explain why.

    The journal’s policy is to have manuscripts reviewed by two expert reviewers. Molecular
    Imaging utilizes a single-blind peer review process in which the reviewer’s name and
    information is withheld from the author. All manuscripts are reviewed as rapidly as possible,
    while maintaining rigor. Reviewers make comments to the author and recommendations to the
    Editor-in-Chief who then makes the final decision.

    As part of the submission process you will be asked to provide the names of up to three peers
    who could be called upon to review your manuscript. Recommended reviewers should be
    experts in their fields and should be able to provide an objective assessment of the manuscript.
    Please be aware of any conflicts of interest when recommending reviewers. Examples of
    conflicts of interest include (but are not limited to) the below: 

    • The reviewer should have no prior knowledge of your submission
    • The reviewer should not have recently collaborated with any of the authors
    • Reviewer nominees from the same institution as any of the authors are not permitted

    You will also be asked to nominate peers who you do not wish to review your manuscript
    (opposed reviewers).

    Please note that the Editors are not obliged to invite any recommended/opposed reviewers to
    assess your manuscript.

    The Editor or members of the Editorial Board may occasionally submit their own manuscripts for
    possible publication in the journal. In these cases, the peer review process will be managed by
    alternative members of the Board and the submitting Editor / Board member will have no
    involvement in the decision-making process.

    Molecular Imaging is committed to delivering high quality, fast peer-review for your paper, and
    as such has partnered with Publons. Publons is a third party service that seeks to track, verify
    and give credit for peer review. Reviewers for Molecular Imaging can opt in to Publons in order
    to claim their reviews or have them automatically verified and added to their reviewer profile.
    Reviewers claiming credit for their review will be associated with the relevant journal, but the
    article name, reviewer’s decision and the content of their review is not published on the site.
    For more information visit the Publons website.

    4.2 Authorship

    Papers should only be submitted for consideration once consent is given by all contributing
    authors. Those submitting papers should carefully check that all those whose work contributed
    to the paper are acknowledged as contributing authors.
    The list of authors should include all those who can legitimately claim authorship. This is all
    those who:

    (i) Made a substantial contribution to the concept or design of the work; or acquisition,
    analysis or interpretation of data,
    (ii) Drafted the article or revised it critically for important intellectual content,
    (iii) Approved the version to be published,
    (iv) Each author should have participated sufficiently in the work to take public
    responsibility for appropriate portions of the content.

    Authors should meet the conditions of all of the points above. Each author should have
    participated sufficiently in the work to take public responsibility for appropriate portions of the
    content.

    When a large, multicentre group has conducted the work, the group should identify the
    individuals who accept direct responsibility for the manuscript. These individuals should fully
    meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone
    does not constitute authorship, although all contributors who do not meet the criteria for
    authorship should be listed in the Acknowledgments section. Please refer to the International 
    Committee of Medical Journal Editors (ICMJE) authorship guidelines
    for more information on
    authorship.

    4.3 Acknowledgements

    All contributors who do not meet the criteria for authorship should be listed in an
    Acknowledgements section. Examples of those who might be acknowledged include a person
    who provided purely technical help, or a department chair who provided only general support.

    4.3.1 Writing assistance

    Individuals who provided writing assistance, e.g. from a specialist communications company, do
    not qualify as authors and so should be included in the Acknowledgements section. Authors
    must disclose any writing assistance – including the individual’s name, company and level of
    input – and identify the entity that paid for this assistance.
    It is not necessary to disclose use of language polishing services.

    Any acknowledgements should appear first at the end of your article prior to your Declaration of
    Conflicting Interests (if applicable), any notes and your References.

    4.4 Funding

    Molecular Imaging requires all authors to acknowledge their funding in a consistent fashion
    under a separate heading. Please visit the Funding Acknowledgements page on the SAGE
    Journal Author Gateway to confirm the format of the acknowledgment text in the event of
    funding, or state that: This research received no specific grant from any funding agency in the
    public, commercial, or not-for-profit sectors.

    4.5 Declaration of conflicting interests

    It is the policy of Molecular Imaging to require a declaration of conflicting interests from all
    authors enabling a statement to be carried within the paginated pages of all published articles.

    Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of
    your manuscript, after any acknowledgements and prior to the references. If no conflict exists,
    please state that ‘The Author(s) declare(s) that there is no conflict of interest’.

    For guidance on conflict of interest statements, please see the ICMJE recommendations.

    4.6 Research ethics and patient consent

    Medical research involving human subjects must be conducted according to the World Medical
    Association Declaration of Helsinki
    .

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct,
    Reporting, Editing, and Publication of Scholarly Work in Medical Journals
    , and all papers
    reporting animal and/or human studies must state in the methods section that the relevant 
    Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure
    that you have provided the full name and institution of the review committee, in addition to the
    approval number.

    For research articles, authors are also required to state in the methods section whether
    participants provided informed consent and whether the consent was written or verbal.
    Information on informed consent to report individual cases or case series should be included in
    the manuscript text. A statement is required regarding whether written informed consent for
    patient information and images to be published was provided by the patient(s) or a legally
    authorized representative.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants.

    All research involving animals submitted for publication must be approved by an ethics
    committee with oversight of the facility in which the studies were conducted. The journal has
    adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals
    published by the International Association of Veterinary Editors.

    4.7 Clinical trials

    Molecular Imaging conforms to the ICMJE requirement that clinical trials are registered in a
    WHO-approved public trials registry at or before the time of first patient enrolment as a
    condition of consideration for publication. The trial registry name and URL, and registration
    number must be included at the end of the abstract.

    4.8 Reporting guidelines

    The relevant EQUATOR Network reporting guidelines should be followed depending on the type
    of study. For example, all randomized controlled trials submitted for publication should include
    a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should
    be uploaded with your submission as a supplementary file. Systematic reviews and metaanalyses
    should include the completed PRISMA flow chart as a cited figure and the completed
    PRISMA checklist should be uploaded with your submission as a supplementary file. The
    EQUATOR wizard can help you identify the appropriate guideline.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

    4.9 Data

    SAGE acknowledges the importance of research data availability as an integral part of the
    research and verification process for academic journal articles.

    Molecular Imaging requests all authors submitting any primary data used in their research
    articles alongside their article submissions to be published in the online version of the journal, or
    provide detailed information in their articles on how the data can be obtained. This information
    should include links to third-party data repositories or detailed contact information for third-
    party data sources. Data available only on an author-maintained website will need to be loaded
    onto either the journal’s platform or a third-party platform to ensure continuing accessibility.
    Examples of data types include but are not limited to statistical data files, replication code, text
    files, audio files, images, videos, appendices, and additional charts and graphs necessary to
    understand the original research. The editor(s) can also grant exceptions for data that cannot
    legally or ethically be released. All data submitted should comply with Institutional or Ethical
    Review Board requirements and applicable government regulations. For further information,
    please contact the editorial office.

    Back to top

    5. Publishing policies

    5.1 Publication ethics

    SAGE is committed to upholding the integrity of the academic record. We encourage authors to
    refer to the Committee on Publication Ethics’ International Standards for Authors and view the
    Publication Ethics page on the SAGE Author Gateway.

    5.1.1 Plagiarism

    Molecular Imaging and SAGE take issues of copyright infringement, plagiarism or other breaches
    of best practice in publication very seriously. We seek to protect the rights of our authors and
    we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to
    protect the reputation of the journal against malpractice. Submitted articles may be checked
    with duplication-checking software. Where an article, for example, is found to have plagiarized
    other work or included third-party copyright material without permission or with insufficient
    acknowledgement, or where the authorship of the article is contested, we reserve the right to
    take action including, but not limited to: publishing an erratum or corrigendum (correction);
    retracting the article; taking up the matter with the head of department or dean of the author's
    institution and/or relevant academic bodies or societies; or taking appropriate legal action.

    5.1.2 Prior publication

    If material has been previously published, it is not generally acceptable for publication in a SAGE
    journal. However, there are certain circumstances where previously published material can be
    considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in
    doubt, contact the Editor at the address given below.

    5.2 Contributor's publishing agreement

    Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s
    Publishing Agreement. Molecular Imaging publishes manuscripts under Creative Commons
    licenses
    . The standard license for the journal is Creative Commons by Attribution NonCommercial
    (CC BY-NC), which allows others to re-use the work without permission as long as
    the work is properly referenced and the use is non-commercial. For more information, you are
    advised to visit SAGE's OA licenses page.

    Alternative license arrangements are available, for example, to meet particular funder
    mandates, made at the author’s request. 

    Back to top

    6. Preparing your manuscript

    6.1 Word processing formats

    The preferred formats for your manuscript are Word, RTF, XLS. LaTeX files are also accepted.
    Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our
    Author Gateway. The text should be double-spaced throughout and with a minimum of 3cm for
    left and right hand margins and 5cm at head and foot. Text should be standard 10 or 12 point.

    6.2 Artwork, figures and other graphics

    For guidance on the preparation of illustrations, pictures and graphs in electronic format, please
    visit SAGE’s Manuscript Submission Guidelines.

    Figures supplied in color will appear in color online.

    6.3 Supplementary material

    This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images
    etc.) alongside the full-text of the article. These will be subjected to peer-review alongside the
    article. For more information please refer to our guidelines on submitting supplementary files,
    which can be found within our Manuscript Submission Guidelines page. 

    6.4 Reference style

    Molecular Imaging adheres to the SAGE Vancouver reference style. Please review the guidelines
    on SAGE Vancouver
    to ensure your manuscript conforms to this reference style.

    If you use EndNote to manage references, you can download the SAGE Vancouver output file
    here
    .

    6.5 English language editing services

    Authors seeking assistance with English language editing, translation, or figure and manuscript
    formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit
    SAGE Language Services on our Journal Author Gateway for further information.

    Back to top

    7. Submitting your manuscript

    7.1 How to submit your manuscript

    Molecular Imaging is hosted on SAGE Track, a web based online submission and peer review
    system powered by ScholarOne™ Manuscripts. Visit https://mc.manuscriptcentral.com/mix to
    login and submit your article online. 

    IMPORTANT: Please check whether you already have an account in the system before trying to
    create a new one. If you have reviewed or authored for the journal in the past year it is likely
    that you will have had an account created. For further guidance on submitting your manuscript
    online please visit ScholarOne Online Help.

    7.2 Title, keywords and abstracts

    Please supply a title, short title, an abstract and keywords to accompany your article. The title,
    keywords and abstract are key to ensuring readers find your article online through online search
    engines such as Google. Please refer to the information and guidance on how best to title your
    article, write your abstract and select your keywords by visiting the SAGE Journal Author
    Gateway for guidelines on How to Help Readers Find Your Article Online.

    7.3 Information required for completing your submission

    Provide full contact details for the corresponding author including email, mailing address and
    telephone numbers. Academic affiliations are required for all co-authors. These details should
    be presented separately to the main text of the article to facilitate anonymous peer review.

    You will be asked to provide contact details and academic affiliations for all co-authors via the
    submission system and identify who is to be the corresponding author. These details must
    match what appears on your manuscript. At this stage please ensure you have included all the
    required statements and declarations and uploaded any additional supplementary files
    (including reporting guidelines where relevant).

    7.4 ORCID

    As part of our commitment to ensuring an ethical, transparent and fair peer review process
    SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID
    provides a persistent digital identifier that distinguishes researchers from every other researcher
    and, through integration in key research workflows such as manuscript and grant submission,
    supports automated linkages between researchers and their professional activities ensuring that
    their work is recognized.
    We encourage all authors to add their ORCIDs to their SAGE Track accounts and include their
    ORCIDs as part of the submission process. If you don’t already have one you can create one
    here.

    7.5 Permissions

    Authors are responsible for obtaining permission from copyright holders for reproducing any
    illustrations, tables, figures or lengthy quotations previously published elsewhere. For further
    information including guidance on fair dealing for criticism and review, please visit our
    Frequently Asked Questions on the SAGE Journal Author Gateway.

    Back to top

    8. On acceptance and publication

    If your paper is accepted for publication after peer review, you will first be asked to complete the
    contributor’s publishing agreement. Once your manuscript files have been checked for SAGE Production,
    the corresponding author will be asked to pay the article processing charge (APC) via a payment link.
    Once the APC has been processed, your article will be prepared for publication and can appear online
    within an average of 30 days. Please note that no production work will occur on your paper until the
    APC has been received.

    8.1 SAGE Production

    Your SAGE Production Editor will keep you informed as to your article’s progress throughout the
    production process. Proofs will be sent by PDF to the corresponding author and should be
    returned promptly. Authors are reminded to check their proofs carefully to confirm that all
    author information, including names, affiliations, sequence and contact details are correct, and
    that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there
    are any changes to the author list at this stage all authors will be required to complete and sign
    a form authorizing the change.

    8.2 Online publication

    One of the many benefits of publishing your research in an open access journal is the speed to
    publication. With no page count constraints, your article will be published online in a fully
    citable form with a DOI number as soon as it has completed the production process. At this time
    it will be completely free to view and download for all. Articles are batched every month, and
    are then available in the Archive.

    8.3 Promoting your article

    Publication is not the end of the process! You can help disseminate your paper and ensure it is
    as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help
    you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.
    In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich,
    share, and measure the impact of their article. Find out how to maximize your article’s impact
    with Kudos

    Back to top

    9. Further information

    Any correspondence, queries or additional requests for information on the Manuscript Submission
    process should be sent to the Molecular Imaging editorial office as follows:

    erin.obrien@sagepub.com 

    Back to top